THE AI-BOOSTER
FOR SKIN PATHOLOGY
Innovative
transformation in skin pathology
Through the use of state-of-the-art artificial intelligence, aisencia® streamlines the workflow in skin pathology to meet the growing demand for fast, precise, and accessible diagnoses
At aisencia®, we explore and develop in ultra-close cooperation with world leading skin pathologists to meet their current and future needs
Partner / Supporters
Already analyzed samples
AI-assisted skin diagnoses
Publications
Our partners
Recent posts
Explore the recent happenings, developments, and trends in our continuous endeavor to revolutionize pathology
aisencia® secures €150 000 BRE-Up funding for “DERM-BOOST”
aisencia GmbH has been awarded €150,000 in EU funding through the BRE-Up program to further develop its digital, AI-powered software solutions Vistaneos and Cutaneos 80.
aisencia® expands to Australia and welcomes new investor
We are extremely proud to welcome Pathscan Pty Ltd. from Australia as a strategic partner and investor—alongside industry leaders Dr. Ian Katz and Paul Richard.
aisencia® partners with PathPresenter!
We are thrilled to announce an strategic partnership with PathPresenter. This collaboration marks a significant milestone by expanding our offerings to the US market.
Introducing Vistaneos: A New Era of Seamless Dermatopathology
This innovative product integrates a laboratory information system, an image management system, and DermPath AI, enabling a seamlessly optimized laboratory workflow.
Stage Two 2024: Double Success for aisencia®!
On October 30-31, 2024, Berlin hosted the Stage Two finals, where aisencia® spectacularly earned double recognition from both b2venture and xdeck, who were impressed by our technology.
Stage Two 2024: aisencia® Nominated for Top Competition!
We are thrilled to announce that aisencia has been nominated for the Stage Two competition, Europe’s largest university venture event, taking place on October 30-31, 2024 in Berlin.
Supported by
You want to know more information about our products?
